Changes in the risk of death after HIV seroconversion compared with mortality in the general population.
about
Increased mortality and AIDS-like immunopathology in wild chimpanzees infected with SIVcpzManaging drug interactions in HIV-infected adults with comorbid illnessHIV infection and older Americans: the public health perspectiveIncomplete immune recovery in HIV infection: mechanisms, relevance for clinical care, and possible solutionsImpact of non-HIV and HIV risk factors on survival in HIV-infected patients on HAART: a population-based nationwide cohort studyTimeliness of clinic attendance is a good predictor of virological response and resistance to antiretroviral drugs in HIV-infected patientsThe burden of image based emphysema and bronchiolitis in HIV-infected individuals on antiretroviral therapyThe CD4:CD8 ratio is associated with markers of age-associated disease in virally suppressed HIV-infected patients with immunological recoveryFocus Group Evaluation of the LIVE Network-An Audio Music Program to Promote ART Adherence Self-Management.Life expectancy after HIV diagnosis based on data from the counseling center for behavioral diseases.Engagement-in-care during the first 5 years after HIV diagnosis: data from a cohort of newly HIV-diagnosed individuals in a large US city.Association of HIV infection, demographic and cardiovascular risk factors with all-cause mortality in the recent HAART era.Smoking Cessation Interventions in HIV-Infected Adults in North America: A Literature Review.High mortality among male HIV-infected patients after prison release: ART is not enough after incarceration with HIV.HIV-infected individuals with low CD4/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk of non-AIDS morbidity and mortality.Developing a Bayesian adaptive design for a phase I clinical trial: a case study for a novel HIV treatment.Effect of baseline HIV disease parameters on CD4+ T cell recovery after antiretroviral therapy initiation in Kenyan women.Narrowing the Gap in Life Expectancy Between HIV-Infected and HIV-Uninfected Individuals With Access to CareExcess mortality in patients with AIDS in the era of highly active antiretroviral therapy: temporal changes and risk factors.Anti-HIV-1 activity of weekly or biweekly treatment with subcutaneous PRO 140, a CCR5 monoclonal antibody.When to start antiretroviral therapyIs the incidence of invasive vulvar cancer increasing in the United States?Virological failure and all-cause mortality in HIV-positive adults with low-level viremia during antiretroviral treatment.AIDS-related and non-AIDS-related mortality in the Asia-Pacific region in the era of combination antiretroviral treatment.Kaposi sarcoma incidence and survival among HIV-infected homosexual men after HIV seroconversionMortality by causes in HIV-infected adults: comparison with the general population.Patterns, trends and sex differences in HIV/AIDS reported mortality in Latin American countries: 1996-2007Psychosocial burdens negatively impact HIV antiretroviral adherence in gay, bisexual, and other men who have sex with men aged 50 and olderNovel protease inhibitors (PIs) containing macrocyclic components and 3(R),3a(S),6a(R)-bis-tetrahydrofuranylurethane that are potent against multi-PI-resistant HIV-1 variants in vitro.Th17, gut, and HIV: therapeutic implicationsProspective study of bone mineral density changes in aging men with or at risk for HIV infection.HIV infection, inflammation, immunosenescence, and aging.Differences in HIV natural history among African and non-African seroconverters in Europe and seroconverters in sub-Saharan Africa.Inflammation and mortality in HIV-infected adults: analysis of the FRAM study cohort.Efficacy of new antiretroviral drugs in treatment-experienced HIV-infected patients: a systematic review and meta-analysis of recent randomized controlled trials.Ambulatory care for HIV-infected patients: differences in outcomes between hospital-based units and private practices: analysis of the RESINA cohort.Animal models for viral infection and cell exhaustion.Race, kidney disease progression, and mortality risk in HIV-infected persons.A history of alcohol dependence augments HIV-associated neurocognitive deficits in persons aged 60 and older.Reconstitution of intestinal CD4 and Th17 T cells in antiretroviral therapy suppressed HIV-infected subjects: implication for residual immune activation from the results of a clinical trial.
P2860
Q22251087-5D545729-18E5-487F-9368-357D89BCD0C7Q26825406-EC6DA942-EE7C-4259-8A09-30BE56968F68Q26858824-445CC279-E206-4AA6-A896-0429A25BCC9AQ27021524-1825FD35-0FA6-4BD5-B897-E2A89EE1BEC3Q28479266-849DE1B5-7B37-4A0A-800F-89F688D90443Q28484929-801B4A8B-E4B2-4BB1-82F3-8EAE347B5F8FQ28544453-69B590C6-6B2F-493F-AF22-BA5296DE3178Q29307877-E1A4D28F-DB93-48E6-A672-491681F98FBAQ30353427-2C486BEB-D580-4CEB-8E4D-A3E40E7A4FC8Q30756408-01A715C2-87C5-416F-BDDE-EE617CCB86FDQ30840171-B2B676F4-D8B9-4326-A56A-D66F4DF3DF1FQ33563357-88D5D28A-3FB6-4278-8AAE-7477EC67287BQ33613909-C3567F35-30A4-47B4-9905-5BAC22A5DD87Q33614946-2539269B-7799-4E67-8023-D0E9D358B489Q33618542-5452C6EE-ECDE-43AC-8D65-3F0032A1F13DQ33626194-1E123452-B303-475D-AE90-24DAE501A6FDQ33631098-5A76E684-56CB-4D6E-962C-694A10A2CD56Q33668524-8E116AF4-58DE-4332-93F1-3D26F227CE46Q33687645-4A9D5336-A6E2-4752-ACBD-35D59EBAC302Q33798442-7D331065-5A70-4DB9-B4D4-B43C5F7837DCQ33799012-7D3E2BAB-2BD5-400C-B141-7187C4D89F78Q33845651-16F29A59-7745-42BE-920E-D138C3C95B7AQ33880782-F908C49E-D4FB-4178-BFEC-6F2D7F5DC411Q33888740-74F9B4DF-01F4-4322-B0E5-5BF837384449Q33888845-970B6107-A7B6-4B4C-8110-0B4609AAF2F9Q33898621-CE248FBE-24F5-4CBC-B176-7E97EED91A4BQ33975593-C861F875-13E7-49C5-B281-4495DCC61C9FQ34021581-24771030-816D-40FF-B560-BC478EB91EB5Q34045363-23414CEE-795B-4E4C-BEF7-463CB12FE2BEQ34050602-97A80B55-503A-4A84-8A10-EC67BE591674Q34116648-E22AB0BC-542B-4776-A45A-C9E6436070D3Q34150710-833A03F0-C0A9-44D7-A156-B0A67238A306Q34193108-3341944C-4C76-424F-9354-03D82D411589Q34204026-DA637312-0CCA-4C02-99F6-E7CD06FB759BQ34235156-6550358E-03FF-4D04-807E-3D8BBBFBA08AQ34253604-5A4E5B57-DFED-4C6D-9A60-B0D96B9EA473Q34267776-D617E3CF-B30B-4526-96B1-B1214ABE8EBCQ34362733-B36348B0-3DE1-407B-839C-0E1829832251Q34388983-11224371-35A3-43C9-A7F7-6E0B65B10DA7Q34394987-B290524A-974D-4DE2-8074-CEEF9317199B
P2860
Changes in the risk of death after HIV seroconversion compared with mortality in the general population.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Changes in the risk of death a ...... ity in the general population.
@ast
Changes in the risk of death a ...... ity in the general population.
@en
Changes in the risk of death a ...... ity in the general population.
@nl
type
label
Changes in the risk of death a ...... ity in the general population.
@ast
Changes in the risk of death a ...... ity in the general population.
@en
Changes in the risk of death a ...... ity in the general population.
@nl
prefLabel
Changes in the risk of death a ...... ity in the general population.
@ast
Changes in the risk of death a ...... ity in the general population.
@en
Changes in the risk of death a ...... ity in the general population.
@nl
P2093
P356
P1476
Changes in the risk of death a ...... ity in the general population.
@en
P2093
Anne M Johnson
CASCADE Collaboration
Faroudy Boufassa
Krishnan Bhaskaran
Mette Sannes
Osamah Hamouda
P356
10.1001/JAMA.300.1.51
P407
P577
2008-07-01T00:00:00Z